Tics are sudden, rapid, non-rhytmic, repetitive, motor movements or vocalizations. The mean age of onset is approximately 5 years old.
Tourette's syndrome is the most common form of tic disorder.
There is a strong genetic component showing a 10- to 100-fold increase in the rates of tics and Tourette's syndrome among first-degree relatives of Tourette's syndrome patients.
Simple motor tics are restricted to a single or a few muscle groups and last less than a fraction of a second.
Complex motor tics involve larger muscle groups, usually last longer and appear purposeful and goal-directed.

Tourette's Syndrome & Other Tic Disorders References

  1. Bagheri MM, Kerbeshian J, Burd L. Recognition and management of Tourette's syndrome and tic disorders. Am Fam Physician. 1999 Apr;59(8):2263-2272, 2274. PMID: 10221310
  2. Bloch M, State M, Pittenger C. Recent advances in Tourette syndrome. Curr Opin Neurol. 2011 Apr;24(2):119-125. PMID: 21386676
  3. Bestha DP, Jeevarakshagan S, Madaan V. Management of tics and Tourette's disorder: an update. Expert Opin Pharmacother. 2010 Aug;11(11):1813-1822. PMID: 20459362
  4. Cavanna AE, Eddy CM, Mitchell R, et al. An approach to deep brain stimulation for severe treatment-refractory Tourette syndrome: the UK perspective. Br J Neurosurg. 2011 Feb;25(1):38-44. PMID: 21158507
  5. Cath DC, Hedderly T, Ludolph AG, et al; ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry. 2011 Apr;20(4):155-171. doi: 10.1007/s00787-011-0164-6. PMID: 21445723
  6. Jankovic J. Tourette's syndrome. N Engl J Med. 2001 Oct;345(16):1184-1192. PMID: 11642235
  7. Kurlan R. Tourette's syndrome. N Engl J Med. 2010 Dec;363(24):2332-2338. PMID: 21142535
  8. Marcus D, Kurlan R. Tics and its disorders. Neurol Clin. 2001 Aug;19(3):735-758. PMID: 11532652
  9. Leckman JF. Tourette's syndrome. Lancet. 2002 Nov;360(9345):1577-1586. PMID: 12443611
  10. Muller-Vahl KR. The treatment of Tourette's syndrome: current opinions. Expert Opin Pharmacother. 2002 Jul;3(7):899-914. PMID: 12083990
  11. Rickards H. Republished review: Tourette's syndrome and other tic disorders. Postgrad Med J. 2011 Mar;87(1024):142-149. PMID: 21303820
  12. Roessner V, Plessen KJ, Rothenberger A, et al; ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry. 2011 Apr;20(4):173-196. doi: 10.1007/s00787-011-0163-7. PMID: 21445724
  13. MedWorm
  14. MedWorm
  15. MedWorm
  16. Jankovic J. Tourette syndrome. UpToDate. Feb 2019. Accessed 21 Sep 2015.
  17. Black KJ. Tourette syndrome and other tic disorders. eMedicine. Mar 2007
  18. Robertson W. Tourette syndrome and other tic disorders. eMedicine. Jun 2011. Accessed 15 Aug 2011
  19. American Psychiatric Association. Tic disorders. In: Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013:81.
  20. Scahill L, Erenberg G, Berlin CM Jr, et al. Contemporary assessment and pharmacotherapy of tourette syndrome. NeuroRx. 2006 Apr;3(2):192-206. PMID: 16554257
  21. Verdellen C, van de Griendt J, Hartmann A, et al. European guidelines for tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry. 2011;20(4):197-207. doi: 10.1007/s00787-011-0167-3. Accessed 24 Apr 2015. PMID: 21445725
  22. Porta M, Sassi M, Cavallazzi M, et al. Tourette’s syndrome and role of tetrabenazine: review and personal experience. Clin Drug Investig. 2008;28(7):443-459. PMID: 18544005
  23. Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 May;92(19):896-906. doi: 10.1212/WNL.0000000000007466. PMID: 31061208
  24. Pringsheim T. Canadian guidelines for the evidence-based treatment of Tourette syndrome.
Editor's Recommendations
Most Read Articles
23 Apr 2018
Long‐term treatment with perampanel in the adjunctive setting appears to provide improved seizure control without raising new safety/tolerability signals in patients with epilepsy, particularly those with secondarily generalized seizures at baseline, according to the results of an open-label extension of phase III trials.
Audrey Abella, 20 Mar 2020
The addition of highly purified cannabidiol (CBD) into an antiepileptic regimen led to reductions in convulsive seizure rates in children with Dravet syndrome (DS), the GWPCARE2* study has shown.
27 May 2020
High rather than low levels of neonatal 25(OH)D3 pose an increased risk of incident epilepsy in early childhood, a finding that may be attributed to chance, confounding, or late gestational vitamin D exposure, according to a study.
Jairia Dela Cruz, 29 Jan 2020
In the treatment of idiopathic generalized epilepsy, switching from valproate to other antiepileptic drugs due to potential childbearing issues may prove detrimental, heightening the risk of poor seizure control, as shown in a recent study.